Halozyme Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $168.7M | $66.8M | $43.3M | $61.4M | $27.4M | $99.5M | $52.4M | $82.8M |
| Accounts Receivable | $22.1M | $15.7M | $32.4M | $9.1M | $9.1M | $15.7M | $2.3M | $2.3M |
| Inventory | $5.1M | $14.6M | $9.5M | $6.4M | $6.2M | $2.7M | $567.3K | $193.4K |
| Total Current Assets | $510.4M | $256.5M | $171.8M | $161.3M | $95.2M | $130.6M | $64.0M | $89.5M |
| Property, Plant & Equipment | $3.5M | $4.3M | $3.9M | $3.0M | $3.4M | $3.7M | $1.8M | $1.8M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $519.9M | $261.5M | $181.8M | $166.0M | $101.8M | $134.7M | $65.8M | $91.3M |
| Liabilities | ||||||||
| Accounts Payable | $7.9M | $3.6M | $4.5M | $3.0M | $3.1M | $2.3M | $7.6M | $3.8M |
| Total Current Liabilities | $131.3M | $54.6M | $62.5M | $24.3M | $24.9M | $18.9M | $17.3M | $15.3M |
| Long-Term Debt | $125.1M | $199.2M | $28.0M | $49.9M | $49.8M | $29.7M | $0 | — |
| Total Liabilities | $311.6M | $294.0M | $138.8M | $124.6M | $121.8M | $85.9M | $54.9M | $71.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-522.4M | $-585.3M | $-482.7M | $-450.4M | $-382.1M | $-298.6M | $-245.0M | $-225.3M |
| Total Stockholders' Equity | $208.4M | $-32.5M | $43.0M | $41.4M | $-20.0M | $48.9M | $10.9M | $20.4M |